NCT03102476View on ClinicalTrials.gov

Environmental Effects Type 1 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 2, 2018

Study Completion Date

February 2, 2018

Conditions
Type1diabetes
Interventions
DRUG

Humalog

Subcutaneous injection of Humalog and assessing Pharmacokinetics and Pharmacodynamics properties of Humalog under different environmental conditions

Trial Locations (1)

HU32RW

Hull and East Yorkshire NHS Trust, Hull

All Listed Sponsors
lead

University of Hull

OTHER

NCT03102476 - Environmental Effects Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter